TP53-altered chronic lymphocytic leukemia treated with firstline Bruton's tyrosine kinase inhibitor-based therapy: A retrospective analysis.
Cherng HJ, Khwaja R, Kanagal-Shamanna R, Tang G, Burger J, Thompson P, Ferrajoli A, Estrov Z, Sasaki K, Sampath D, Wang X, Kantarjian H, Keating M, Wierda WG, Jain N.
Cherng HJ, et al. Among authors: khwaja r.
Am J Hematol. 2022 Aug;97(8):1005-1012. doi: 10.1002/ajh.26595. Epub 2022 May 30.
Am J Hematol. 2022.
PMID: 35567779
Free PMC article.